The staff neurologist at Cleveland Clinic’s Mellen Center for Multiple Sclerosis spoke about the current understanding of the biomarker.
Robert Fox, MD
Advertisement
Articles by Robert Fox, MD
Advertisement
Advertisement
Advertisement
Trending on NeurologyLive
1
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
2
Current Challenges and New Opportunities Ahead for Women in Neurology
3
Managing Dyskinesia Through Continuous Infusion Therapy
4
2025 Women in Neurology Conference: Educating, Mentoring, and Networking
5
